116 related articles for article (PubMed ID: 5583282)
1. Tay-Sachs disease. Four Swedish cases with special regard to a genealogical investigation.
Eeg-Olofsson O; Akesson HO
Acta Neurol Scand; 1967; 43(S31):60. PubMed ID: 5583282
[No Abstract] [Full Text] [Related]
2. The fetal aspects of Tay-Sachs disease.
Schneck L; Adachi M; Volk BW
Pediatrics; 1972 Mar; 49(3):342-51. PubMed ID: 4334559
[No Abstract] [Full Text] [Related]
3. [Tay-Sachs' disease].
Clausen J; Melchior JC
Ugeskr Laeger; 1974 Feb; 136(6):305. PubMed ID: 4820552
[No Abstract] [Full Text] [Related]
4. [Lipoidosis--with special reference to metachromatic leucodystrophy and Tay-Sachs disease].
Yokoi S
Nihon Rinsho; 1967 Oct; 25(8):1597-606. PubMed ID: 4868956
[No Abstract] [Full Text] [Related]
5. Tay, Sachs et al.
Raine DN
Lancet; 1969 Nov; 2(7627):959-60. PubMed ID: 4186617
[No Abstract] [Full Text] [Related]
6. Genealogical study of lipoid proteinosis in South Africa.
Heyl T
Br J Dermatol; 1970 Sep; 83(3):338-40. PubMed ID: 5479304
[No Abstract] [Full Text] [Related]
7. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
Tallman JF; Johnson WG; Brady RO
J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
[TBL] [Abstract][Full Text] [Related]
8. Membranous cytoplasmic bodies from Tay-Sachs disease. Gm-1-gangliosidosis (generalized gangliosidosis).
Suzuki K; Chen GC
J Neuropathol Exp Neurol; 1968 Jan; 27(1):142-3. PubMed ID: 5656560
[No Abstract] [Full Text] [Related]
9. Tay-Sachs disease: genetic drift among the Ashkenazim Jews.
Fraikor AL
Soc Biol; 1977; 24(2):117-34. PubMed ID: 897699
[No Abstract] [Full Text] [Related]
10. Molecular mechanism of Tay-Sachs disease.
Lester R; Hill MW; Bangham AD
Nature; 1972 Mar; 236(5340):32-3. PubMed ID: 4553636
[No Abstract] [Full Text] [Related]
11. Asialo GM-ganglioside in brain fetal Tay-Sachs disease.
Schneck L; Pinkett B; Volk BW
J Neurochem; 1975 Jan; 24(1):183-4. PubMed ID: 1110360
[No Abstract] [Full Text] [Related]
12. Action of neuraminidase from Clostridium perfringens of Tay-Sachs ganglioside.
Wenger DA; Wardell S
Physiol Chem Phys; 1972; 4(3):224-30. PubMed ID: 4376840
[No Abstract] [Full Text] [Related]
13. Tay-sachs disease. Demonstration of the stored ganglioside in cultured cells from brain biopsy.
Batzdorf U; Sarlieve LL; Gold VA; Menkes JH
Arch Neurol; 1969 Jun; 20(6):650-2. PubMed ID: 4890200
[No Abstract] [Full Text] [Related]
14. Founder effect in Tay-Sachs disease.
Knudson AG
Am J Hum Genet; 1973 Jan; 25(1):108. PubMed ID: 4684502
[No Abstract] [Full Text] [Related]
15. Elevated frequency of Tay-Sachs disease among Ashkenazic Jews unlikely by genetic drift alone.
Chakravarti A; Chakraborty R
Am J Hum Genet; 1978 May; 30(3):256-61. PubMed ID: 677122
[TBL] [Abstract][Full Text] [Related]
16. A molecular variant of Tay-Sachs disease in a non-Ashkenazi Jewish family.
Bach G; Cohen MM
Prog Clin Biol Res; 1977; 18():189-94. PubMed ID: 601076
[No Abstract] [Full Text] [Related]
17. Approaches to the control and prevention of Tay-Sachs disease.
Kaback MM; Zeiger RS; Reynolds LW; Sonneborn M
Prog Med Genet; 1974; 10():103-34. PubMed ID: 4620174
[TBL] [Abstract][Full Text] [Related]
18. Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease).
Krivit W; Desnick RJ; Lee J; Moller J; Wright F; Sweeley CC; Snyder PD; Sharp HL
Am J Med; 1972 Jun; 52(6):763-70. PubMed ID: 5030173
[No Abstract] [Full Text] [Related]
19. Founder effect in Tay-Sachs disease unlikely.
Myrianthopoulos NC; Naylor AF; Aronson SM
Am J Hum Genet; 1972 May; 24(3):341-2. PubMed ID: 5028972
[No Abstract] [Full Text] [Related]
20. Controversy in human genetics: founder effect in Tay-Sachs disease.
Chase GA; McKusick VA
Am J Hum Genet; 1972 May; 24(3):339-40. PubMed ID: 5028971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
